Boycott C, Beetch M, Yang T, Lubecka K, Ma Y, Zhang J
Epigenetics. 2022; 17(11):1513-1534.
PMID: 35502615
PMC: 9586690.
DOI: 10.1080/15592294.2022.2069386.
Seltenrich N
Environ Health Perspect. 2016; 124(11):A199-A205.
PMID: 27801648
PMC: 5089893.
DOI: 10.1289/ehp.124-A199.
Igarashi I, Makino T, Kai K, Teranishi M, Takasaki W, Satoh H
J Vet Med Sci. 2015; 78(1):113-6.
PMID: 26268664
PMC: 4751127.
DOI: 10.1292/jvms.14-0437.
de Conti A, Kobets T, Tryndyak V, Burnett S, Han T, Fuscoe J
Toxicol Sci. 2014; 144(2):217-26.
PMID: 25539665
PMC: 4372661.
DOI: 10.1093/toxsci/kfu313.
J Toxicol Pathol. 2013; 26(2):259-62.
PMID: 23914069
PMC: 3695349.
DOI: 10.1293/tox.26.259.
Glycogenotic hepatocellular carcinoma with glycogen-ground-glass hepatocytes: a heuristically highly relevant phenotype.
Bannasch P
World J Gastroenterol. 2012; 18(46):6701-8.
PMID: 23239906
PMC: 3520157.
DOI: 10.3748/wjg.v18.i46.6701.
A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals.
Ito N, Tamano S, Shirai T
Cancer Sci. 2003; 94(1):3-8.
PMID: 12708466
PMC: 11160283.
DOI: 10.1111/j.1349-7006.2003.tb01343.x.
A 2-year dose-response study of lesion sequences during hepatocellular carcinogenesis in the male B6C3F(1) mouse given the drinking water chemical dichloroacetic acid.
Carter J, Carter H, Deddens J, Hurst B, George M, DeAngelo A
Environ Health Perspect. 2003; 111(1):53-64.
PMID: 12515679
PMC: 1241306.
DOI: 10.1289/ehp.5442.
Dose- and sex-related carcinogenesis by N-bis(2-hydroxypropyl)nitrosamine in Wistar rats.
Moreira E, de Camargo J, Rodrigues M, Barbisan L, Salvadori D
Jpn J Cancer Res. 2000; 91(4):368-74.
PMID: 10804283
PMC: 5926461.
DOI: 10.1111/j.1349-7006.2000.tb00954.x.
Multiple occurrence of borderline hepatocellular nodules in human cirrhotic livers: possible multicentric origin of hepatocellular carcinoma.
Terada T, Nakanuma Y
Virchows Arch. 1995; 427(4):379-83.
PMID: 8548122
DOI: 10.1007/BF00199386.
Suppression by oestrogen of hepatocellular tumourigenesis induced in mice by 3'-methyl-4-dimethylaminoazobenzene.
Yamamoto R, Tatsuta M, Terada N
Br J Cancer. 1993; 68(2):303-7.
PMID: 8394104
PMC: 1968552.
DOI: 10.1038/bjc.1993.332.
Demonstration of initiation potential of carcinogens by induction of preneoplastic glutathione S-transferase P-form-positive liver cell foci: possible in vivo assay system for environmental carcinogens.
Tsuda H, Matsumoto K, Ogino H, Ito M, Hirono I, Nagao M
Jpn J Cancer Res. 1993; 84(3):230-6.
PMID: 7683635
PMC: 5919141.
DOI: 10.1111/j.1349-7006.1993.tb02861.x.
Hepatocarcinogenesis in rodents and humans.
Kitagawa T, Miyasaka K, Kanda H, Yasui H, Hino O
J Cancer Res Clin Oncol. 1995; 121(9-10):511-5.
PMID: 7559729
DOI: 10.1007/BF01197762.
Hepatocyte growth factor enhancement of preneoplastic hepatic foci development in rats treated with diethylnitrosamine and N-ethyl-N-hydroxyethylnitrosamine.
Yaono M, Hasegawa R, Mizoguchi Y, Futakuchi M, Nakamura T, Ito N
Jpn J Cancer Res. 1995; 86(8):718-23.
PMID: 7559093
PMC: 5920913.
DOI: 10.1111/j.1349-7006.1995.tb02459.x.
Hepatic neoplasia: reflections and ruminations.
Aterman K
Virchows Arch. 1995; 427(1):1-18.
PMID: 7551337
DOI: 10.1007/BF00203732.
The ultrastructural features of aflatoxin B1-induced lesions in the rat liver.
Pritchard D, Butler W
Br J Exp Pathol. 1988; 69(6):793-804.
PMID: 3146339
PMC: 2013296.
Glutathione S-transferases and hepatocarcinogenesis.
Sato K
Jpn J Cancer Res. 1988; 79(5):556-72.
PMID: 3136107
PMC: 5917566.
DOI: 10.1111/j.1349-7006.1988.tb00022.x.
Decrease in glucokinase and glucose-6-phosphatase and increase in hexokinase in putative preneoplastic lesions of rat liver.
Fischer G, Ruschenburg I, Eigenbrodt E, Katz N
J Cancer Res Clin Oncol. 1987; 113(5):430-6.
PMID: 3040765
DOI: 10.1007/BF00390036.
Induction and promotion of gamma-glutamyltranspeptidase-positive foci in the rat liver by methylglyoxal.
Martelli A, Ghia M, Mereto E, Marinari U, Brambilla G
Jpn J Cancer Res. 1988; 79(6):666-9.
PMID: 2900825
PMC: 5917568.
DOI: 10.1111/j.1349-7006.1988.tb02218.x.
Enzymes of glutathione metabolism as biochemical markers during hepatocarcinogenesis.
Hendrich S, Pitot H
Cancer Metastasis Rev. 1987; 6(2):155-78.
PMID: 2885099
DOI: 10.1007/BF00052847.
